Sevo Nutraceuticals Financing
Sevo Nutraceuticals, Inc., Corporation just submitted form D because of $70,000 debt financing. This is a new filing. Sevo Nutraceuticals was able to finance itself with $70,000. That is 100.00% of the offering. The total financing amount was $70,000. The financing document was filed on 2016-07-12. The reason for the financing was: unspecified.
Sevo Nutraceuticals is based in Massachusetts. The firm’s business is not disclosed. The form D was signed by Bernard D Prusaczyk Jr Chief Executive Officer. The company was incorporated in 2012. The filler’s address is: 850 Winter Street, Waltham, Ma, Massachusetts, 02451. Bernard D. Prusaczyk is the related person in the form and it has address: 850 Winter Street, Waltham, Ma, Massachusetts, 02451-1420. Link to Sevo Nutraceuticals Filing: 000155270316000002.
Analysis of Sevo Nutraceuticals Offering
On average, startups in the not disclosed sector, sell 67.77% of the total offering amount. Sevo Nutraceuticals sold 100.00% of the offering. Could this mean that the trust in Sevo Nutraceuticals is high? The average investment offering size for companies in all industries in our database is $3.05 million. The offering was 97.70% smaller than the average of $3.05 million. Of course this should not be seen as negative. Companies raise funds for different reasons and needs. The minimum investment for this fundraising was set at $10000. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Sevo Nutraceuticals Also
The Form D signed by Bernard D Prusaczyk Jr might help Sevo Nutraceuticals, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.